Chat
Telangiectasia Syndrome (BMP9/GDF2) Sequencing (INACTIVE as of 11/15/21)
Copy Utility
Ordering Recommendation
Diagnostic test for individuals suspected to have a telangiectasia syndrome without a pathogenic variant in the ACVRL1, ENG, or SMAD4 gene.
Mnemonic
Methodology
Polymerase Chain Reaction/Sequencing
Performed
Varies
Reported
21-28 days
New York DOH Approval Status
Specimen Required
Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).
Transport 3 mL whole blood. (Min: 1 mL)
Refrigerated.
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
Reference Interval
By report
Interpretive Data
Background Information for BMP9/GDF2 Sequencing:
Characteristics: Telangiectases (blanching pink to red vascular lesions) of the hands, mouth, face, limbs and trunk. Epistaxis (recurring nosebleeds).
Prevalence: Unknown.
Inheritance: Autosomal dominant.
Penetrance: NA.
Cause: Pathogenic BMP9/GDF2 gene mutations.
Clinical Sensitivity: BMP9/GDF2 mutations detected in ~1 percent of individuals suspected to have a hereditary telangiectasia syndrome, but with no mutation in the ACVRL1, ENG or SMAD4 genes.
Methodology: Bidirectional sequencing of the entire BMP9 coding region and intron-exon boundaries.
Analytical Sensitivity and Specificity: 99 percent.
Limitations: Diagnostic errors can occur due to rare sequence variations. Regulatory region mutations, deep intronic mutations, and large deletions/duplications will not be detected.
Laboratory Developed Test (LDT)
Note
Diagnostic test for individuals suspected to have a telangiectasia syndrome but no mutation in ACVRL1, ENG or SMAD.
Hotline History
CPT Codes
81479
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2010016 | BMP9/GDF2 Sequencing Specimen | |
| 2010017 | BMP9/GDF2 Sequencing Interp | 53837-1 |
Aliases
- ACVRL1, ENG
- Hereditary Hemorrhagic Telangiectasia
Feedback
